Schonfeld Strategic Advisors’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20,500	Closed	-$323K	–	2526
2023 Q4	$323K	Buy	+20,500	New	+$197K	﹤0.01%	1407

Schonfeld Strategic Advisors's ICVX Position: Q1 2024 in Review

Schonfeld Strategic Advisors sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 20,500 shares — an estimated $323K sold.

Schonfeld Strategic Advisors first reported a position in ICVX in Q4 2023 and held it in 1 quarter. The position peaked at $323K in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

Schonfeld Strategic Advisors reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Schonfeld Strategic Advisors sold 20,500 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $323K.
Schonfeld Strategic Advisors first reported a position in Icosavax, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Schonfeld Strategic Advisors's Icosavax, Inc. Common Stock position peaked at $323K in Q4 2023.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2024, filed 15 May 2024.